TBR1 regulates autism risk genes in the developing neocortex

Genome Res. 2016 Aug;26(8):1013-22. doi: 10.1101/gr.203612.115. Epub 2016 Jun 20.

Abstract

Exome sequencing studies have identified multiple genes harboring de novo loss-of-function (LoF) variants in individuals with autism spectrum disorders (ASD), including TBR1, a master regulator of cortical development. We performed ChIP-seq for TBR1 during mouse cortical neurogenesis and show that TBR1-bound regions are enriched adjacent to ASD genes. ASD genes were also enriched among genes that are differentially expressed in Tbr1 knockouts, which together with the ChIP-seq data, suggests direct transcriptional regulation. Of the nine ASD genes examined, seven were misexpressed in the cortices of Tbr1 knockout mice, including six with increased expression in the deep cortical layers. ASD genes with adjacent cortical TBR1 ChIP-seq peaks also showed unusually low levels of LoF mutations in a reference human population and among Icelanders. We then leveraged TBR1 binding to identify an appealing subset of candidate ASD genes. Our findings highlight a TBR1-regulated network of ASD genes in the developing neocortex that are relatively intolerant to LoF mutations, indicating that these genes may play critical roles in normal cortical development.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Autism Spectrum Disorder / genetics*
  • Autism Spectrum Disorder / physiopathology
  • DNA-Binding Proteins / genetics*
  • Disease Models, Animal
  • Exome / genetics
  • Gene Expression Regulation
  • Gene Knockout Techniques
  • Humans
  • Mice
  • Mutation
  • Neocortex / growth & development
  • Neocortex / physiopathology*
  • Neurogenesis / genetics*
  • Neurons / metabolism
  • Neurons / pathology
  • Risk Factors

Substances

  • DNA-Binding Proteins
  • Tbr1 protein, mouse